Imerys Talc America: Asbestos-Contaminated Talc, Baby Powder Supply & the 2019 Bankruptcy Trust

Company History: From Luzenac to Imerys

Imerys Talc America is the American subsidiary of Imerys S.A., a French multinational mining and mineral processing company. The entity most consumers and litigants know as “Imerys” operated under several corporate names across the decades of its most significant asbestos-related activity. From the 1970s through the 1990s, the talc mining and supply operation was conducted under the name Luzenac America, Inc., which itself had roots in earlier talc mining enterprises in Montana going back to the mid-twentieth century. Rio Tinto Minerals, a division of the Anglo-Australian mining giant Rio Tinto Group, subsequently acquired the talc operations before Imerys S.A. purchased the global talc business from Rio Tinto in 2011 for approximately 340 million dollars. Throughout every corporate reorganization and change in ownership, the same mines in Montana and Vermont continued producing cosmetic-grade talc, the same supply relationships with major consumer product manufacturers continued, and the same fundamental question about asbestos contamination in that talc remained unresolved — and, according to documents later produced in litigation, was actively managed rather than disclosed.

The company’s talc mining operations in Montana were centered on deposits in the Three Forks area and in the Yellowstone region of the state, where geological formations produced talc of the mineral purity and particle size characteristics sought by cosmetic manufacturers. Montana talc has long been commercially prized for its whiteness, softness, and lubricity — exactly the properties that made it suitable for baby powder, body powder, and other personal care applications. Vermont talc operations provided additional supply capacity and served certain industrial grades as well as cosmetic markets. These mines were among the most productive cosmetic-grade talc operations in North America, and for a major consumer products company like Johnson & Johnson, which required consistent, high-volume supply of cosmetic talc for its flagship Baby Powder product, Imerys and its predecessors were the natural and, for extended periods, essentially exclusive source of that raw material.

The supply relationship between the company (under its various names) and Johnson & Johnson extended over many decades. Johnson’s Baby Powder, first introduced in the late nineteenth century and established as one of the most recognized consumer brands in American history, was formulated with talc as its active ingredient. Imerys and its predecessors supplied a substantial portion — and at times virtually all — of the talc that went into Johnson’s Baby Powder production. The companies maintained long-term supply contracts, participated in joint quality testing programs, and exchanged internal test data regarding talc composition and purity. It was precisely within those quality testing programs and internal communications that evidence of asbestos contamination began to accumulate, and it was precisely within that shared documentary record that some of the most damaging litigation evidence would later be found.

The geological reality underlying the entire liability is straightforward: talc and asbestos are both silicate minerals, and they often occur in the same geological formations. In the particular deposits mined in Vermont and Montana, the talc-bearing rock also contained tremolite asbestos — a form of amphibole asbestos that is recognized as one of the most biologically aggressive carcinogenic mineral fibers known. Tremolite fibers are needle-like, resistant to dissolution in biological tissue, and capable of migrating from pleural surfaces deep into lung tissue where they trigger the inflammatory and carcinogenic cascades associated with mesothelioma. Unlike chrysotile (white asbestos), which some researchers have argued is partially biopersistent, tremolite is an amphibole fiber with extremely long biological persistence, meaning it remains in tissue essentially permanently once inhaled or ingested. The contamination of cosmetic talc with tremolite asbestos was not a theoretical risk — it was a documented, recurring finding in internal test results spanning decades.

In 2018 and 2019, Reuters and the New York Times published major investigative reports based on internal company documents, deposition transcripts, and confidential test records obtained through litigation discovery. Those reports revealed that tests of talc samples from the Johnson & Johnson supply chain had detected asbestos contamination dating back to the 1970s, and that the findings had not consistently been disclosed to regulators including the U.S. Food and Drug Administration, to J&J consumers, or to the public. The Reuters investigation specifically cited internal Imerys and predecessor company documents showing employees were aware of the contamination risk, and that internal discussions had taken place about the implications for product safety and corporate liability. These investigative reports accelerated the pace of litigation and increased the financial pressure on Imerys Talc America to a degree that made continued litigation defense untenable.

Products & Exposure Pathways

Imerys Talc America’s liability does not arise from a manufactured asbestos product in the traditional sense — there was no asbestos-fiber insulation, no pipe covering, no brake pad. Instead, the exposure mechanism was more insidious: asbestos fibers were present as trace contaminants within what was marketed and sold as a pure cosmetic-grade talc. Women who applied Johnson’s Baby Powder to their bodies — many of them daily, for decades — inhaled and ingested fine talc dust with every application. Workers who processed, packaged, or quality-tested talc at Imerys facilities were exposed occupationally. And for the miners who worked underground or in open-cut operations in Montana and Vermont, the exposure was direct and sustained throughout their working lives.

The consumer exposure pathway differs fundamentally from industrial asbestos exposure in one critical way: the women and caregivers who used Johnson’s Baby Powder were not warned. Industrial insulation workers, even those who received wholly inadequate protection, operated in a world where the occupational hazard of asbestos was — by the 1970s — broadly if belatedly recognized. A homemaker applying baby powder to herself or her infant after a bath had no reason to suspect she was potentially inhaling a carcinogenic mineral fiber. The daily repetition of that exposure over 20, 30, or 40 years, combined with the long latency period of mesothelioma, meant that many women diagnosed in the 2010s and beyond had accumulated their critical exposure dose in the 1970s and 1980s — during years when the contamination was known internally but not disclosed publicly.

Who Was Exposed to Imerys Talc’s Asbestos-Contaminated Products

The population of people potentially harmed by Imerys-supplied asbestos-contaminated talc is unusually diverse compared to the industrial asbestos exposure cases that dominate most trust fund histories. The largest single category of claimants consists of women who used Johnson’s Baby Powder or Shower to Shower as a regular personal hygiene product — particularly those who applied it to the perineal region, a practice that was widely encouraged in advertising for these products from the 1950s onward. Epidemiological studies and the pathology findings in mesothelioma cases among these women established a biological link between perineal talc application and pleural and peritoneal mesothelioma, as well as ovarian cancer. The peritoneal route of exposure — in which talc particles travel through the reproductive tract to the abdominal cavity — is a distinct pathway from the inhalation route and produces peritoneal mesothelioma rather than the pleural form more commonly seen in industrial asbestos cases.

Caregivers — parents and grandparents who regularly applied baby powder to infants during diapering and bathing — represent a second significant exposure population. These individuals, predominantly but not exclusively women, applied the powder by shaking it from the container or by pouring and patting, both of which generate a visible talc aerosol in the immediate breathing zone of the caregiver. Repeated exposure of this type over months or years of infant care produced measurable inhalation doses, and caregivers who developed mesothelioma or ovarian cancer have successfully pursued claims connecting their disease to this pattern of use.

Workers at Imerys’s Montana and Vermont talc mining and processing operations represent the second major exposure population. These individuals worked in direct contact with raw talc ore containing asbestos-bearing mineral formations. Underground miners drilling and blasting talc ore were exposed to the full composition of the ore body, including asbestos-contaminated seams. Surface processing workers who crushed, milled, classified, and bagged the finished talc worked in environments where airborne talc dust — and any asbestos fibers it contained — was a constant ambient presence. Industrial hygiene monitoring at these facilities was not always systematic, and in the early decades of operation, the full implications of tremolite contamination in the talc stream were not addressed through engineering controls, respiratory protection, or medical surveillance with the rigor that the hazard warranted.

Workers employed at Johnson & Johnson manufacturing facilities where Baby Powder was produced form an additional category of potentially exposed individuals. The bulk talc received from Imerys was handled, measured, and poured into containers by workers on the filling line, and handling operations that disturbed large quantities of bulk talc powder generated airborne dust in production areas. The extent of asbestos contamination in any given production batch was not individually tested, and contamination levels varied across lots and over time, meaning that the degree of asbestos exposure experienced by filling line workers depended in part on which batches of talc they handled and during which periods of production.

Family members of mine workers and processing plant employees who were exposed through take-home contamination — asbestos fibers carried on work clothing, in hair, and on skin into the home environment — may also be eligible claimants. Para-occupational exposure through household contact with an asbestos-exposed worker has been recognized in mesothelioma cases across many exposure categories and is factually documented in cases arising from talc mine environments where tremolite fiber is present in the ore.

Trust Fund & Legal Status

On February 13, 2019, Imerys Talc America, Inc., along with affiliated entities Imerys Talc Vermont, Inc. and Imerys Talc Canada Inc., filed voluntary petitions for Chapter 11 bankruptcy protection in the United States Bankruptcy Court for the District of Delaware. The filing was a direct consequence of the escalating volume of asbestos and ovarian cancer personal injury lawsuits that had been accumulating against the company, particularly following the wave of mass media coverage of the contamination allegations and the string of significant trial verdicts in favor of plaintiffs who had used Johnson’s Baby Powder. At the time of filing, Imerys faced tens of thousands of pending personal injury claims and projected that the volume of future claims from individuals who had not yet been diagnosed would make continued litigation defense financially impossible.

The Chapter 11 reorganization of Imerys Talc America resulted in the creation of the Imerys Talc Personal Injury Trust. Under the confirmed plan of reorganization, Imerys contributed assets to the trust, and the trust assumed responsibility for all present and future asbestos-related and talc-related personal injury claims against the Imerys entities. The trust operates under a trust distribution procedure that establishes qualifying disease categories, medical criteria for eligibility, scheduled compensation values, and the claims review process. Mesothelioma — both pleural and peritoneal — qualifies for the highest scheduled compensation under the trust’s payment schedule, reflecting the disease’s severity and its established biological link to asbestos fiber inhalation and ingestion. Ovarian cancer claims are also compensable under the trust’s distribution procedure, recognizing the epidemiological and biological evidence linking perineal talc use to ovarian malignancy.

It is critical for claimants and attorneys to understand that the Imerys Talc America bankruptcy is entirely separate from Johnson & Johnson’s attempted bankruptcy maneuvers through LTL Management LLC and Red River Talc LLC. Imerys filed and reorganized under conventional Chapter 11 proceedings without employing the controversial Texas Two-Step divisional merger strategy that J&J later attempted. The Imerys trust is therefore a functioning, established compensation vehicle operating under the standard asbestos trust framework used by dozens of other bankrupt asbestos defendants. A talc claimant who used Johnson’s Baby Powder may have separate and independent grounds to file against the Imerys Trust (for the talc supplier’s role) and to pursue litigation against Johnson & Johnson directly (for the manufacturer’s independent role in marketing and selling the contaminated product). These claims are not mutually exclusive, and an experienced asbestos attorney will evaluate both avenues of recovery.

Before filing bankruptcy, Imerys had faced a series of significant trial verdicts that demonstrated the full extent of its litigation exposure. Juries across multiple jurisdictions had returned multimillion-dollar verdicts against Imerys in mesothelioma cases, often alongside verdicts against Johnson & Johnson in cases where both companies were co-defendants. Evidence presented at trial included internal Imerys documents and predecessor company documents showing asbestos test results, internal communications about contamination findings, and product safety analyses that were not publicly disclosed. The cumulative weight of this documentary record, the trial results, and the continuing growth in the number of diagnosed claimants made the bankruptcy filing a practical inevitability for a company of Imerys Talc America’s financial scale.

The trust distribution procedure for the Imerys Talc Personal Injury Trust requires claimants to submit qualifying medical documentation establishing a diagnosis that meets the trust’s disease criteria, along with documentation of exposure to a product supplied by Imerys or its predecessors. For consumer claimants, establishing product exposure typically involves personal purchase records, advertising materials identifying the relevant product, sworn statements by the claimant or family members, and, where available, expert testimony regarding the contamination levels present in the specific product lines used. For mine and plant workers, standard employment and wage records, union records, and facility employment documentation serve as the primary exposure evidence. An asbestos attorney experienced with the Imerys trust will compile the complete evidentiary package required for a successful claim submission.

Frequently Asked Questions